Glukem Biocare Private Limited, a active private limited company, was established on 20 October 2014 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2014PTC096067. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.15 Cr and a paid-up capital of ₹9.90 M.
It upholds a compliant status. Employing 231 professional, Its leadership includes Rakesh Chinnala (Director), Varun Vihar Madupaduga (Director), Rami Reddy Kolli (Director). Past directors included Rami Reddy Kolli, Omkar Reddy Bommu. It holds ₹2.96 Cr open charges and ₹13.05 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Module No. 206/A, Emd Business Park , Nsic, E.C.I.L. Post,, Hyderabad, Telangana, 500062.
U24232TG2014PTC096067
096067
20 October 2014
₹5.15 Cr
₹9.90 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Glukem Biocare Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Chinnala | Director | 20 Oct 2014 | Current |
| Varun Vihar Madupaduga | Director | 20 Oct 2014 | Current |
| Rami Reddy Kolli | Director | 05 May 2015 | Current |
| Hazra Susanta Kumar | Director | 20 Oct 2014 | Current |
| Ramanaiah Madupaduga | Director | 20 Oct 2014 | Current |
| Omkar Reddy Bommu | Director | 05 May 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Glukem Biocare Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 24.29% increase. The company also saw a substantial improvement in profitability, with a 27.34% increase in profit. The company's net worth Soared by an impressive increase of 39.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Glukem Biocare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹29,599,000.00
₹130,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Aug 2025 | Axis Bank Limited | ₹3.00 M | Open |
| 07 Feb 2025 | Axis Bank Limited | ₹1.00 Cr | Open |
| 25 Jan 2024 | Axis Bank Limited | ₹3.30 M | Open |
| 28 Oct 2022 | Axis Bank Limited | ₹9.45 M | Open |
| 06 Oct 2022 | Hdfc Bank Limited | ₹3.85 M | Open |
Explore comprehensive loan charge details -
Glukem Biocare has a workforce of 231 employees as of Mar 04, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Glukem Biocare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glukem Biocare's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Axis Bank Limited amounted to Rs. 0.30 Cr with Charge ID 101159967 was registered on 19 Aug 2025. was recorded as a recent event.
A charge registered on 05 Aug 2020 via Charge ID 100362456 with Axis Bank Limited was fully satisfied on 17 Apr 2025. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 101065246 was registered on 07 Feb 2025. was completed.
Progress on Glukem Biocare Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Glukem Biocare Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
The activity A charge with Axis Bank Limited amounted to Rs. 0.33 Cr with Charge ID 100860746 was registered on 25 Jan 2024. was completed.
The CIN of Glukem Biocare Private Limited is U24232TG2014PTC096067.
Glukem Biocare Private Limited is headquartered at Module No. 206/A, Emd Business Park , Nsic, E.C.I.L. Post,, Hyderabad, Telangana, 500062.
Glukem Biocare Private Limited was incorporated on 20 October 2014.
The current directors of Glukem Biocare Private Limited are
The primary industry of Glukem Biocare Private Limited is Manufacturing.
Glukem Biocare Private Limited is unlisted.
The authorized capital of Glukem Biocare Private Limited is ₹5.15 Cr, and the paid-up capital is ₹9.90 M.
The compliance status of Glukem Biocare Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX